Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress

Journal of Neuroscience

Volumn 27, Issue 27, 2007, Pages 7196-7207

  Gray, Jason D ^a   Punsoni, Michael ^a   Tabori, Nora E ^a,b   Melton, Jay T ^a   Fanslow, Victoria ^a   Ward, Mary J ^a   Zupan, Bojana ^a   Menzer, David ^a   Rice, Jackson ^a   Drake, Carrie T ^a   Romeo, Russell D ^b   Brake, Wayne G ^c   Torres Reveron, Annelyn ^a   Milner, Teresa A ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c and Applied Physiology   (Canada)

Author keywords

ADHD; Hippocampus; Hypothalamus; Prefrontal cortex; Ritalin; Striatum

Indexed keywords

CATECHOLAMINE; GENE PRODUCT; METHYLPHENIDATE; NEUROPEPTIDE Y; NEUROTRANSMITTER; NORADRENALIN TRANSPORTER; POLYSIALYLATED FORM OF NEURAL CELL ADHESION MOLECULE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APPETITE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN REGION; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DISEASE MARKER; DRUG EFFECT; FEMALE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MOTIVATION; NEUROCHEMISTRY; NISSL STAINING; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; STRESS;

AGE FACTORS; ANIMALS; APPETITE; BEHAVIOR, ANIMAL; BRAIN; COGNITION; FEMALE; MALE; METHYLPHENIDATE; MOTIVATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

EID: 34447125680     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0109-07.2007     Document Type: Article

References (108)

1. Angold A, Erkanli A, Egger HL, Costello EJ (2000) Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39:975-984.
2. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384.
3. Arvidsson U, Riedl M, Elde R, Meister B (1997) Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 378:454-467.
4. Barone Jr S, Das KP, Lassiter TL, White LD (2000) Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21:15-36.
5. Bayer SA, Altman J, Russo RJ, Zhang X (1993) Timetables of neurogenesis in the human brain based on experimentally induced patterns in the rat. Neurotoxicology 14:83-144.
6. Bellinger LL, Bernardis LL (2002) The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies. Physiol Behav 76:431-442.
7. Berendse HW, Galis-de Graaf Y, Groenewegen HJ (1992) Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316:314-347.
8. Berger B, Verney C, Febvret A, Vigny A, Helle KB (1985) Postnatal ontogenesis of the dopaminergic innervation in the rat anterior cingulate cortex (area 24). Immunocytochemical and catecholamine fluorescence histochemical analysis. Brain Res 353:31-47.
9. Berger B, Gaspar P, Verney C (1991) Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
10. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003) Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317-1329.
11. Brake WG, Sullivan RM, Flores G, Srivastava LK, Gratton A (1999) Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the adult rat. Brain Res 831:25-32.
12. Brezun JM, Daszuta A (2000) Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 10:37-46.
13. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG (2003) Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 467:1-10.
14. Brown P, Molliver ME (2000) Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci 20:1952-1963.
15. Carrey N, McFadyen MP, Brown RE (2000) Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. J Child Adolesc Psychopharmacol 10:277-286.
16. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R (2006) Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10:117-123.
17. Chang PC, Aicher SA, Drake CT (2000) Kappa opioid receptors in rat spinal cord vary across the estrous cycle. Brain Res 861:168-172.
18. Commons KG, Milner TA (1995) Ultrastructural heterogeneity of enkephalin-containing neurons in the rat hippocampal formation. J Comp Neurol 358:324-342.
19. Dalley JW, Cardinal RN, Robbins TW (2004) Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28:771-784.
20. Dayas CV, Buller KM, Day TA (2004) Hypothalamic paraventricular nucleus neurons regulate medullary catecholamine cell responses to restraint stress. J Comp Neurol 478:22-34.
21. D'Este L, Casini A, Pontieri FE, Renda TG (2006) Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment. Brain Res 1083:151-158.
22. Dobbing J, Sands J (2000) Comparative aspects of brain growth spurt. Early Hum Dev 3:79-83.
23. Drake CT, Chang PC, Harris JA, Milner TA (2002) Neurons with muopioid receptors interact indirectly with enkephalin-containing neurons in the rat dentate gyrus. Exp Neurol 176:254-261.
24. Elliott RC, Khademi S, Pleasure SJ, Parent JM, Lowenstein DH (2001) Differential regulation of basic helix-loop-helix mRNAs in the dentate gyrus following status epilepticus. Neuroscience 106:79-88.
25. Fallon JH, Loughlin SE (1987) Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. In: Cerebral cortex, Vol 6 (Jones EG, Peters A, eds), pp 41-127. New York: Plenum.
26. Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA, Dayton PG (1974) Metabolism and disposition of methylphenidate-14C: studies in man and animals. J Pharmacol Exp Ther 191:535-547.
27. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, Vinet MC, Friocourt G, McDonnell N, Reiner O, Kahn A, McConnell SK, Berwald-Netter Y, Denoulet P, Chelly J (1999) Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23:247-256.
28. Fu LY, Acuna-Goycolea C, van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24:8741-8751.
29. Gall C, Brecha N, Karten HJ, Chang KJ (1981) Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J Comp Neurol 198:335-350.
30. Gasbarri A, Verney C, Innocenzi R, Campana E, Pacitti C (1994) Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res 668:71-79.
31. Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS (1996) Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58:231-239.
32. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL (2000) Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295:51-57.
33. Gooley JJ, Schomer A, Saper CB (2006) The dorsomedial hypothalamic nucleus is critical for the expression of food-entrainable circadian rhythms. Nat Neurosci 9:398-407.
34. Gordon N (1999) Attention deficit hyperactivity disorder: possible causes and treatment. Int J Clin Pract 53:524-528.
35. Gould E, Tanapat P, Rydel T, Hastings N (2000) Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 48:715-720.
36. Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G (2006) Influence of methylphenidate on brain development-an update of recent animal experiments. Behav Brain Funct 2:2.
37. Haas DA, George SR (1989) Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission. Brain Res 498:333-338.
38. Hechtman L (2006) Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Curr Psychiatry Rep 8:398-408.
39. Heimer L, Zahm DS, Alheid GF (1995) Basal ganglia. In: The rat nervous system (Paxinos G, ed), pp 579-628. San Diego: Academic.
40. Hermes SM, Mitchell JL, Aicher SA (2006) Most neurons in the nucleus tractus solitarii do not send collateral projections to multiple autonomic targets in the rat brain. Exp Neurol 198:539-551.
41. Herrick SP, Waters EM, Drake CT, McEwen BS, Milner TA (2006) Extranuclear estrogen receptor beta immunoreactivity is on doublecortincontaining cells in the adult and neonatal rat dentate gyrus. Brain Res 1121:46-58.
42. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:557-580.
43. Izenwasser S, Coy AE, Ladenheim B, Loeloff RJ, Cadet JL, French D (1999) Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 373:187-193.
44. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB (1999) Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 38:557-565.
45. Jessberger S, Romer B, Babu H, Kempermann G (2005) Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells. Exp Neurol 196:342-351.
46. Joh TH, Ross ME (1983) Preparation of catecholamine synthesizing enzymes as immunogen for immunocytochemistry. In: Immunocytochemistry (Cuello AC, ed), pp 121-138. New York: Wiley.
47. Jones SP, Rahimi O, O'Boyle MP, Diaz DL, Claiborne BJ (2003) Maturation of granule cell dendrites after mossy fiber arrival in hippocampal field CA3. Hippocampus 13:413-427.
48. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, Liu H, Hollenberg AN, Friedman JM, Elmquist JK (2005) Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 482:217-243.
49. Klintsova AY, Greenough WT (1999) Synaptic plasticity in cortical systems. Curr Opin Neurobiol 9:203-208.
50. Kriegstein AR, Noctor SC (2004) Patterns of neuronal migration in the embryonic cortex. Trends Neurosci 27:392-399.
51. Krimer LS, Jakab RL, Goldman-Rakic PS (1997) Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex. J Neurosci 17:7450-7461.
52. Kuczenski R, Segal DS (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem [Erratum (1997) 69:1332] 68:2032-2037.
53. Kuczenski R, Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271.
54. Lagace DC, Yee JK, Bolanos CA, Eisch AJ (2006) Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biol Psychiatry 60:1121-1130.
55. Lambe EK, Krimer LS, Goldman-Rakic PS (2000) Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20:8780-8787.
56. Levitt P, Harvey JA, Friedman E, Simansky K., Murphy EH (1997) New evidence for neurotransmitter involvement in brain development. Trends Neurosci 20:269-274.
57. Lewis DE, Shellard L, Koeslag DG, Boer DE, McCarthy HD, McKibbin PE, Russell JC, Williams G (1993) Intense exercise and food restriction cause similar hypothalamic neuropeptide Y increases in rats. Am J Physiol 264:E279-E284.
58. Loy R, Koziell JD, Lindsay JD, Moore RY (1980) Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 189:699-710.
59. Marshall E (2000) Duke study faults overuse of stimulants for children. Science 289:721.
60. McFadyen MP, Brown RE, Carrey N (2002) Subchronic methylphenidate administration has no effect on locomotion, emotional behavior, or water maze learning in prepubertal mice. Dev Psychobiol 41:123-132.
61. McFadyen-Leussis MP, Lewis SP, Bond TL, Carrey N, Brown RE (2004) Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice. Pharmacol Biochem Behav 77:491-500.
62. McGaugh JL (2000) Memory - a century of consolidation. Science 287:248 -251.
63. Milner TA (1991) Cholinergic neurons in the rat septal complex: ultrastructural characterization and synaptic relations with catecholaminergic terminals. J Comp Neurol 314:37-54.
64. Milner TA, Bacon CE (1989) Ultrastructural localization of tyrosine hydroxylase-like immunoreactivity in the rat hippocampal formation. J Comp Neurol 281:479-495.
65. Milner TA, Veznedaroglu E (1992) Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus 2:107-126.
66. Milner TA, Veznedaroglu E (1993) Serotonin-containing terminals synapse on septohippocampal neurons in the rat. J Neurosci Res 36:260-271.
67. Milner TA, Reis DJ, Pickel VM, Aicher SA, Giuliano R (1993) Ultrastructural localization and neuroanatomical origins of corticotropin- releasing factor in the rat rostral ventrolateral medulla: implications for central cardiovascular regulation. J Comp Neurol 333:151-167.
68. Milner TA, Wiley RG, Kurucz OS, Prince SR, Pierce JP (1997) Selective changes in hippocampal neuropeptide Y neurons following removal of the cholinergic septal inputs. J Comp Neurol 386:46-59.
69. Milner TA, Rosin DL, Lee A, Aicher SA (1999) Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 821:200-211.
70. Miner LH, Schroeter S, Blakely RD, Sesack SR (2003) Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neurol 466:478-494.
71. Miner LH, Jedema HP, Moore FW, Blakely RD, Grace AA, Sesack SR (2006) Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci 26:1571-1578.
72. Morrow BA, Elsworth JD, Roth RH (2005) Prenatal exposure to cocaine selectively disrupts the development of parvalbumin containing local circuit neurons in the medial prefrontal cortex of the rat. Synapse 56:1-11.
73. Muir JL (1997) Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 56:687-696.
74. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
75. Pierce JP, Kurucz O, Milner TA (1999) The morphometry of a peptidergic transmitter system before and after seizure. I. Dynorphin B-like immunoreactivity in the hippocampal mossy fiber system. Hippocampus 9:255-276.
76. Popper CW (1997) Antidepressants in the treatment of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 58 [Suppl 14]:14 -29; discussion 30-31.
77. Ramos A, Mormede P (1998) Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 22:33-57.
78. Rapport MD, Moffitt C (2002) Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev 22:1107-1131.
79. Rice D, Barone Jr S (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108:511-533.
80. Robinson TE, Kolb B (1999) Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 11:1598-1604.
81. Romijn HJ, Hofman MA, Gramsbergen A (2000) At what age is developing rat cortex comparable to that of the full term human baby? Early Hum Dev 26:61-67.
82. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1998) Differences between electrically-, Ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94:163-171.
83. Sagvolden T, Sergeant JA (1998) Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour [editorial]. Behav Brain Res 94:1-10.
84. Scharfman HE, Goodman JH, Sollas AL (2000) Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J Neurosci 20:6144-6158.
85. Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL (2006) Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 59:243-251.
86. Seki T, Arai Y (1993) Highly polysialylated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dentate gyrus of the adult rat. J Neurosci 13:2351-2358.
87. Sesack SR, Snyder CL, Lewis DA (1995) Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 363:264-280.
88. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697-2708.
89. Severi S, Guidi S, Ciani E, Bartesaghi R (2005) Sex differences in the stereological parameters of the hippocampal dentate gyrus of the guinea-pig before puberty. Neuroscience 132:375-387.
90. Silver LB (1999) Attention deficit hyperactivity disorder. A clinical guide to diagnosis and treatment. Washington DC: American Psychiatric.
91. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152.
92. Spencer SJ, Buller KM, Day TA (2005) Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J Comp Neurol 481:363-376.
93. Swanson LW (1992) Brain maps: structure of the rat brain. Amsterdam: Elsevier.
94. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429-433.
95. Torres-Reveron A, Dow-Edwards DL (2005) Repeated administration of methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood. Psychopharmacology (Berl) 181:38-47.
96. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N (1997) Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50-55.
97. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331.
98. Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P (1999a) Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse 31:59-66.
99. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR (1999b) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 291:409-415.
100. Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding YS, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121(1-5).
101. Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR (1983) Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 226:382-386.
102. Westwood SC, Hanson GR (1999) Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. J Pharmacol Exp Ther 288:1160-1166.
103. Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCracken J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A (2006) Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45:1294-1303.
104. Willuhn I, Sun W, Steiner H (2003) Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context. Eur J Neurosci 17:1053-1066.
105. Yano M, Steiner H (2005a) Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132:855-865.
106. Yano M, Steiner H (2005b) Topography of methylphenidate (Ritalin)-induced gene regulation in the striatum: differential effects on c-fos, substance P and opioid peptides. Neuropsychopharmacology 30:901-915.
107. Yano M, Beverley JA, Steiner H (2006) Inhibition of methylphenidate- induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140:699-709.
108. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025-1030.